Search research articles
Contact Us
Filters
Showing results (11-20 of 354) with videos related to
Page
of 36
Sort By:
Current Pharmaceutical Design
|
September 13, 2013
Bridge between neuroimmunity and traumatic brain injury
Matthew L Kelso, Howard E Gendelman
Current Opinion in Pharmacology
|
November 17, 2015
Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease
Katherine E Olson, Howard E Gendelman
Iscience
|
April 17, 2026
CAR Treg therapies for neurodegenerative diseases
Daniel N Stein, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 2, 2015
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders
Howard E Gendelman, R Lee Mosley
Experimental Neurology
|
January 5, 2010
Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
R Lee Mosley, Howard E Gendelman
Current Opinion in HIV and AIDS
|
September 17, 2014
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders
Howard E Gendelman, Harris A Gelbard
Cellular Immunology
|
July 27, 2011
Proteomic biosignatures for monocyte-macrophage differentiation
Stephanie D Kraft-Terry, Howard E Gendelman
Trends in Neurosciences
|
February 7, 2012
Rodent models for HIV-associated neurocognitive disorders
Santhi Gorantla, Larisa Poluektova, Howard E Gendelman
Methods in Molecular Biology (Clifton, N.J.)
|
August 3, 2005
Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue
Kathleen Borgmann, Howard E Gendelman, Anuja Ghorpade
Journal of Neuroimmunology
|
January 5, 2002
Mononuclear phagocyte biophysiology influences brain transendothelial and tissue migration: implication for HIV-1-associated dementia
Induk Chung, Marina Zelivyanskaya, Howard E Gendelman
Page
of 36
Search research articles
Search
Showing results (11-20 of 354) with videos related to
Sort By:
Page
of 36
Current Pharmaceutical Design
|
September 13, 2013
Bridge between neuroimmunity and traumatic brain injury
Matthew L Kelso, Howard E Gendelman
Current Opinion in Pharmacology
|
November 17, 2015
Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease
Katherine E Olson, Howard E Gendelman
Iscience
|
April 17, 2026
CAR Treg therapies for neurodegenerative diseases
Daniel N Stein, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 2, 2015
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders
Howard E Gendelman, R Lee Mosley
Experimental Neurology
|
January 5, 2010
Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
R Lee Mosley, Howard E Gendelman
Current Opinion in HIV and AIDS
|
September 17, 2014
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders
Howard E Gendelman, Harris A Gelbard
Cellular Immunology
|
July 27, 2011
Proteomic biosignatures for monocyte-macrophage differentiation
Stephanie D Kraft-Terry, Howard E Gendelman
Trends in Neurosciences
|
February 7, 2012
Rodent models for HIV-associated neurocognitive disorders
Santhi Gorantla, Larisa Poluektova, Howard E Gendelman
Methods in Molecular Biology (Clifton, N.J.)
|
August 3, 2005
Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue
Kathleen Borgmann, Howard E Gendelman, Anuja Ghorpade
Journal of Neuroimmunology
|
January 5, 2002
Mononuclear phagocyte biophysiology influences brain transendothelial and tissue migration: implication for HIV-1-associated dementia
Induk Chung, Marina Zelivyanskaya, Howard E Gendelman
Page
of 36